strattera 10 mg kapseli, kova
eli lilly finland oy ab - atomoxetine hydrochloride - kapseli, kova - 10 mg - atomoksetiini
strattera 18 mg kapseli, kova
eli lilly finland oy ab - atomoxetine hydrochloride - kapseli, kova - 18 mg - atomoksetiini
strattera 25 mg kapseli, kova
eli lilly finland oy ab - atomoxetine hydrochloride - kapseli, kova - 25 mg - atomoksetiini
strattera 40 mg kapseli, kova
eli lilly finland oy ab - atomoxetine hydrochloride - kapseli, kova - 40 mg - atomoksetiini
strattera 60 mg kapseli, kova
eli lilly finland oy ab - atomoxetine hydrochloride - kapseli, kova - 60 mg - atomoksetiini
strattera 80 mg kapseli, kova
eli lilly finland oy ab - atomoxetine hydrochloride - kapseli, kova - 80 mg - atomoksetiini
strattera 100 mg kapseli, kova
eli lilly finland oy ab - atomoxetine hydrochloride - kapseli, kova - 100 mg - atomoksetiini
retsevmo
eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiset aineet - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.
anagrelide ratiopharm 1 mg kapseli, kova
teva b.v. - anagrelidi hydrochloridum monohydricum - kapseli, kova - 1 mg - anagrelidi
anagrelide aop 0.5 mg kapseli, kova
aop orphan pharmaceuticals ag - anagrelidi hydrochloridum,anagrelidi hydrochloridum monohydricum - kapseli, kova - 0.5 mg - anagrelidi